Magnesium Research


Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6 Volume 19, numéro 1, March 2006

Explorations Fonctionnelles du Système Nerveux, Centre Hospitalier Universitaire Carémeau, Nîmes, Laboratoire de Biochimie, Centre Hospitalier Universitaire Carémeau, Nîmes, Département de Pharmacologie, Université de Bourgogne, Dijon, Laboratoire de Biochimie, Faculté de Pharmacie, Montpellier (France)

Some previous studies have reported the involvement of magnesium (Mg) deficiency in children with ADHD syndrome. In this work, 40 children with clinical symptoms of ADHD were followed clinically and biologically during a magnesium-vitamin B6 (Mg-B6) regimen (6 mg/kg/d Mg, 0.6 mg/kg/d vit-B6) which was set up for at least 8 weeks. Symptoms of ADHD (hyperactivity, hyperemotivity/aggressiveness, lack of attention at school) were scored (0-4) at different times; in parallel, intraerythrocyte Mg 2+ (Erc-Mg) and blood ionized Ca 2+ (i-Ca) were measured. Children from the ADHD group showed significantly lower Erc-Mg values than control children (n = 36). In almost all cases of ADHD, Mg-B6 regimen for at least two months significantly modified the clinical symptoms of the disease: namely, hyperactivity and hyperemotivity/aggressiveness were reduced, school attention was improved. In parallel, the Mg-B6 regimen led to a significant increase in Erc-Mg values. When the Mg-B6 treatment was stopped, clinical symptoms of the disease reappeared in few weeks together with a decrease in Erc-Mg values. This study brings additional information about the therapeutic role of a Mg-B6 regimen in children with ADHD symptoms.